Rewalk Stock Top Executives

RWLK
 Stock
  

USD 1.05  0.02  1.94%   

Rewalk Robotics employes about 51 people. The company is managed by 23 executives with total tenure of roughly 169 years, averaging almost 7.0 years of service per executive having 2.22 employees per reported executive. Assessment of Rewalk Robotics management performance can provide insight into the firm performance. Note, employee sentiment is becoming a valuable factor that investors use to determine the amount of risk that may be associated with Rewalk Robotics future performance.
Additionally, take a look at Your Equity Center.
  
  Larry Jasinski  CEO
CEO, Director
  Lawrence Jasinski  CEO
CEO, Director
  Jeff Dykan  Chairman
Independent Chairman of the Board

Rewalk Robotics Management Team Effectiveness

Rewalk Robotics has return on total asset (ROA) of (10.57) % which means that it has lost $10.57 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (18.19) %, meaning that it created substantial loss on money invested by shareholders. Rewalk Robotics management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.

Rewalk Robotics Workforce Comparison

Rewalk Robotics is rated second in number of employees category among related companies. The total workforce of Medical Devices industry is at this time estimated at about 46,158. Rewalk Robotics adds roughly 51.0 in number of employees claiming only tiny portion of all equities under Medical Devices industry.

Rewalk Robotics Profit Margins

The company has Profit Margin (PM) of (253.78) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (251.94) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -2.52.

Rewalk Robotics Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Rewalk Robotics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Rewalk Robotics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Rewalk Robotics insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Rewalk Robotics Benchmark Summation

Rewalk Robotics Notable Stakeholders

A Rewalk Robotics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Rewalk Robotics often face trade-offs trying to please all of them. Rewalk Robotics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Rewalk Robotics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Larry Jasinski - CEO, DirectorProfile
Lawrence Jasinski - CEO, DirectorProfile
Jeff Dykan - Independent Chairman of the BoardProfile
John Hamilton - Vice President - Regulatory and ClinicalProfile
Ori Gon - CFOProfile
Kevin Hershberger - CFOProfile
Ori Schellas - Director of OperationsProfile
Jay Kalish - Independent DirectorProfile
Aryeh Dan - DirectorProfile
Miri Pariente - Global Director - QualityProfile
Chunlin Han - DirectorProfile
Yohanan Engelhardt - DirectorProfile
Glenn Muir - Independent DirectorProfile
Wayne Weisman - Independent DirectorProfile
Hadar Ron - Independent DirectorProfile
Deborah DiSanzo - DirectorProfile
Peter Wehrly - Independent DirectorProfile
Yasushi Ichiki - DirectorProfile
Ning Cong - Independent DirectorProfile
Asaf Shinar - Independent DirectorProfile
John Poduska - Independent Director NomineeProfile
Jodi Gricci - VP of Global MarketingProfile
Ofir Koren - VP of RandDProfile

About Rewalk Robotics Management Performance

The success or failure of an entity such as Rewalk Robotics often depends on how effective the management is. Rewalk Robotics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Rewalk management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Rewalk management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please read more on our stock advisor page.
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel. Rewalk Robotics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 51 people.
The data published in Rewalk Robotics' official financial statements usually reflect Rewalk Robotics' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Rewalk Robotics. For example, before you start analyzing numbers published by Rewalk accountants, it's critical to develop an understanding of what Rewalk Robotics' liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Rewalk Robotics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Rewalk Robotics' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Rewalk Robotics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Rewalk Robotics. Please utilize our Beneish M Score to check the likelihood of Rewalk Robotics' management to manipulate its earnings.

Rewalk Robotics Workforce Analysis

Traditionally, organizations such as Rewalk Robotics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Rewalk Robotics within its industry.

Rewalk Robotics Manpower Efficiency

Return on Rewalk Robotics Manpower

Revenue Per Employee108.4 K
Revenue Per Executive240.4 K
Net Loss Per Employee274.9 K
Net Loss Per Executive609.6 K
Working Capital Per Employee381 K
Working Capital Per Executive844.9 K
Additionally, take a look at Your Equity Center. Note that the Rewalk Robotics information on this page should be used as a complementary analysis to other Rewalk Robotics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for Rewalk Stock analysis

When running Rewalk Robotics price analysis, check to measure Rewalk Robotics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rewalk Robotics is operating at the current time. Most of Rewalk Robotics' value examination focuses on studying past and present price action to predict the probability of Rewalk Robotics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Rewalk Robotics' price. Additionally, you may evaluate how the addition of Rewalk Robotics to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Is Rewalk Robotics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rewalk Robotics. If investors know Rewalk will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rewalk Robotics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
63.8 M
Quarterly Revenue Growth YOY
-0.33
Return On Assets
-0.11
Return On Equity
-0.18
The market value of Rewalk Robotics is measured differently than its book value, which is the value of Rewalk that is recorded on the company's balance sheet. Investors also form their own opinion of Rewalk Robotics' value that differs from its market value or its book value, called intrinsic value, which is Rewalk Robotics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rewalk Robotics' market value can be influenced by many factors that don't directly affect Rewalk Robotics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rewalk Robotics' value and its price as these two are different measures arrived at by different means. Investors typically determine Rewalk Robotics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rewalk Robotics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.